GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $15,000 | -25.0% | 42,715 | -0.7% | 0.00% | – |
| Q2 2016 | $20,000 | -68.3% | 43,015 | -6.7% | 0.00% | -100.0% |
| Q1 2016 | $63,000 | +10.5% | 46,115 | +17.9% | 0.00% | 0.0% |
| Q4 2015 | $57,000 | -8.1% | 39,115 | -1.0% | 0.00% | 0.0% |
| Q3 2015 | $62,000 | -4.6% | 39,515 | +2.8% | 0.00% | 0.0% |
| Q2 2015 | $65,000 | +170.8% | 38,440 | +124.3% | 0.00% | – |
| Q1 2015 | $24,000 | +14.3% | 17,140 | +21.2% | 0.00% | – |
| Q4 2014 | $21,000 | -34.4% | 14,140 | -8.4% | 0.00% | – |
| Q3 2014 | $32,000 | -31.9% | 15,429 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $47,000 | +4.4% | 15,429 | -14.9% | 0.00% | 0.0% |
| Q1 2014 | $45,000 | -40.8% | 18,140 | +17.7% | 0.00% | 0.0% |
| Q4 2013 | $76,000 | +171.4% | 15,414 | +20.3% | 0.00% | – |
| Q2 2013 | $28,000 | – | 12,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |